ARIPIPRAZOLE | A204838 | AMNEAL PHARMACEUTICALS
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
OTSUKA PHARMACEUTICAL CO., LTD. v. AMNEAL PHARMACEUTICALS LLC et al 4 patentsANDA 204838Aripiprazole | D.N.J. | 2015-03-02 | Terminated 2019-07-15 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.1711
per ea
Lowest NADAC/Unit
$0.0980
per ea
Brand NDCs
0
Generic NDCs
20
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 65162090103ARIPIPRAZOLE 20 MG TABLET | $0.1711 | EA | Generic | — | 2026-06-17 |
| 00904737004ARIPIPRAZOLE 20 MG TABLET | $0.1711 | EA | Generic | — | 2026-06-17 |
| 65162090109ARIPIPRAZOLE 20 MG TABLET | $0.1711 | EA | Generic | — | 2026-06-17 |
| 00904737104ARIPIPRAZOLE 30 MG TABLET | $0.1670 | EA | Generic | — | 2026-06-17 |
| 65162090209ARIPIPRAZOLE 30 MG TABLET | $0.1670 | EA | Generic | — | 2026-06-17 |
| 65162090203ARIPIPRAZOLE 30 MG TABLET | $0.1670 | EA | Generic | — | 2026-06-17 |
Showing 6 of 20 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.